# Eldecalcitol for GLucocorticoid Induced OsteopoRosIs Versus Alfacalcidol

> **NCT01974167** · NA · UNKNOWN · sponsor: **e-GLORIA trial Protocol Review Committee** · enrollment: 400 (estimated)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** Eldecalcitol
- **DRUG:** Alfacalcidol

## Key facts

- **NCT ID:** NCT01974167
- **Lead sponsor:** e-GLORIA trial Protocol Review Committee
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-12
- **Primary completion:** 2018-02
- **Final completion:** —
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2014-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01974167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01974167, "Eldecalcitol for GLucocorticoid Induced OsteopoRosIs Versus Alfacalcidol". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01974167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*